In this study, we examined the expression of XO in experimental atherosclerosis, and studied the effects of febuxostat, a highly potent inhibitor of XOR, both in vivo in the atherosclerosis model and in vitro in CC-induced inflammation in macrophages. This evidence concerns the gene XDH and atherosclerosis.